Open AccessAn Exploration of Factors Impacting Preexposure Prophylaxis Eligibility and Access Among Syringe Exchange Users
Author(s) -
Alexis M. Roth,
Brenna Aumaier,
Marisa Felsher,
Seth L. Welles,
Ana P. Martínez-Donate,
Martha Chavis,
Barbara Van Der Pol
Publication year - 2018
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000000728
Subject(s) - medicine , pre exposure prophylaxis , psychological intervention , family medicine , syringe , chlamydia , men who have sex with men , human immunodeficiency virus (hiv) , gonorrhea , feeling , nursing , psychiatry , syphilis , psychology , social psychology , immunology
In 2015, approximately 50,000 new HIV infections occurred in the United States, 2,400 of which were attributable to injection drug use. Preexposure prophylaxis (PrEP) has the potential to curb HIV acquisition; however, uptake remains low among persons who inject drugs (PWID). The purpose of the study is to describe PrEP eligibility, willingness to use PrEP, and ability to access PrEP among PWID recruited from a pilot program that paired screening and treatment of sexually transmitted infections with mobile syringe exchange program (SEP) services.